Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey
Journal of the International AIDS Society · 2023
DOI: 10.1002/jia2.26163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, 2023. Verfasst von Jing-Hao Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Sexual and Gender Minorities, Pre-Exposure Prophylaxis, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cheng Kung University Hospital, National Science and Technology Council.
Abstract (Originalsprache)
Introduction
While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir — the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regimen among gay, bisexual and other men who have sex with men (GBMSM) in Taiwan, providing a unique setting to observe the preferences for long‐acting PrEP in a community where the daily regimen is not the mainstream method. This study aimed to determine the preferences for the different forms and dosing intervals of long‐acting PrEP that are currently in the development pipeline.
Methods
We conducted a survey in 2021 by convenience sampling the users of social networking applications for GBMSM in Taiwan. Our survey included questions on sexual behaviours, current PrEP regimens and the preferences for potential candidates of long‐acting PrEP, such as implants, intramuscular and subcutaneous injections. We compared the Likert‐scale preference ratings for potential long‐acting options, and conducted logistic regression analysis to examine the factors associated with a preference for bimonthly intramuscular injections (2M IM) over ED and daily PrEP regimens, respectively.
Results
A total of 1728 responses were eligible for analysis. Three percent of respondents ( n = 52) were daily PrEP users; 11.5% ( n = 198) were ED PrEP users. When not considering cost, current PrEP users—regardless of their original dosing regimen—were most likely to express preferences for monthly oral PrEP, followed by a 6‐month subcutaneous injectable (6M SC) and 2M IM. However, among non‐current PrEP users, monthly oral PrEP was the most preferred form, followed by ED, daily oral and 6M SC injectable. Multivariable logistic regression revealed that current daily users, those willing to take PrEP in the next 6 months and those with more sex partners in the last 12 months had a significant correlation with preferences for the 2M IM injectable over the ED PrEP.
Conclusions
The monthly oral form was the most preferable long‐acting PrEP among GBMSM in Taiwan. Current daily PrEP users preferred the 2M IM injectable over the ED PrEP, which made the 2M IM injectable a potential alternative. Further studies should focus on how the cost and delivery affect PrEP preferences and their actual uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei City Hospital Renai Branch, Taipei, Taiwan.
- HIV Education and Research Taiwan (HEART) Association, Taipei, Taiwan.
- Infection Control Center and Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Institute of Health Behaviors and Community Sciences, National Taiwan University, Taipei, Taiwan.
- The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Jing-Hao Hsu, Stephane Wen-Wei Ku, Poyao Huang, Huei-Jiuan Wu, Carol Strong
Förderung
- National Cheng Kung University Hospital
- National Science and Technology Council
Zitieren
APA
Hsu, J. H., Ku, S. W., Chen, T. W., Li, C. W., Huang, P., Wu, H. J., Bourne, A., & Strong, C. (2023). Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26163
Vancouver
Hsu JH, Ku SW, Chen TW, Li CW, Huang P, Wu HJ, et al. Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey. Journal of the International AIDS Society. 2023. doi:10.1002/jia2.26163
BibTeX
@article{Hsu2023,
author = {Hsu, Jing-Hao and Ku, Stephane Wen-Wei and Chen, Tsai-Wei and Li, Chia-Wen and Huang, Poyao and Wu, Huei-Jiuan and Bourne, Adam and Strong, Carol},
title = {Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey},
journal = {Journal of the International AIDS Society},
year = {2023},
doi = {10.1002/jia2.26163}
}
EUVIMED